Format

Send to

Choose Destination
Clin Lymphoma Myeloma Leuk. 2014 Sep;14 Suppl:S104-10. doi: 10.1016/j.clml.2014.06.021.

Infection control practices in patients with hematological malignancies and multidrug-resistant organisms: special considerations and challenges.

Author information

1
Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
2
Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address: rfchemaly@mdanderson.org.

Abstract

Infectious complications contribute greatly to morbidity and mortality in patients with hematological malignancies. As these patients undergo prolonged chemotherapy and are in frequent contact with health care settings, they are at high risk for nosocomial and health care-associated infections. This long-term relationship with the hospital setting represents a major opportunity for infection prevention. In this review, we describe several infection control strategies that are currently used to reduce the transmission of hospital-acquired infections in patients with hematological malignancies, particularly infections with multidrug-resistant organisms.

KEYWORDS:

Health-care associated infections; Hematological malignancies; Infection control; Multidrug-resistant organisms; prevention

PMID:
25486947
DOI:
10.1016/j.clml.2014.06.021
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center